173 related articles for article (PubMed ID: 25625510)
1. Comparing WTP values of different types of QALY gain elicited from the general public.
Pennington M; Baker R; Brouwer W; Mason H; Hansen DG; Robinson A; Donaldson C;
Health Econ; 2015 Mar; 24(3):280-93. PubMed ID: 25625510
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of willingness to pay per quality-adjusted life year for a cure: A contingent valuation method using a scenario-based survey.
Song HJ; Lee EK
Medicine (Baltimore); 2018 Sep; 97(38):e12453. PubMed ID: 30235732
[TBL] [Abstract][Full Text] [Related]
3. Willingness to pay for a QALY based on community member and patient preferences for temporary health states associated with herpes zoster.
Lieu TA; Ray GT; Ortega-Sanchez IR; Kleinman K; Rusinak D; Prosser LA
Pharmacoeconomics; 2009; 27(12):1005-16. PubMed ID: 19908925
[TBL] [Abstract][Full Text] [Related]
4. How you ask is what you get: Framing effects in willingness-to-pay for a QALY.
Ahlert M; Breyer F; Schwettmann L
Soc Sci Med; 2016 Feb; 150():40-8. PubMed ID: 26730880
[TBL] [Abstract][Full Text] [Related]
5. A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population.
Mavrodi A; Aletras V
Value Health Reg Issues; 2020 Sep; 22():36-43. PubMed ID: 32731168
[TBL] [Abstract][Full Text] [Related]
6. Estimating a WTP-based value of a QALY: the 'chained' approach.
Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
[TBL] [Abstract][Full Text] [Related]
7. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
Olofsson S; Norrlid H; Persson U
J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?
Nimdet K; Chaiyakunapruk N; Vichansavakul K; Ngorsuraches S
PLoS One; 2015; 10(4):e0122760. PubMed ID: 25855971
[TBL] [Abstract][Full Text] [Related]
9. The value of a QALY: individual willingness to pay for health gains under risk.
Bobinac A; van Exel J; Rutten FF; Brouwer WB
Pharmacoeconomics; 2014 Jan; 32(1):75-86. PubMed ID: 24293198
[TBL] [Abstract][Full Text] [Related]
10. Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project.
Baker R; Bateman I; Donaldson C; Jones-Lee M; Lancsar E; Loomes G; Mason H; Odejar M; Pinto Prades JL; Robinson A; Ryan M; Shackley P; Smith R; Sugden R; Wildman J;
Health Technol Assess; 2010 May; 14(27):1-162. PubMed ID: 20525460
[TBL] [Abstract][Full Text] [Related]
11. Willingness to pay for a quality-adjusted life-year: the individual perspective.
Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
[TBL] [Abstract][Full Text] [Related]
12. Willingness to pay for a QALY.
Gyrd-Hansen D
Health Econ; 2003 Dec; 12(12):1049-60. PubMed ID: 14673813
[TBL] [Abstract][Full Text] [Related]
13. Estimating a constant WTP for a QALY-a mission impossible?
Sund B; Svensson M
Eur J Health Econ; 2018 Jul; 19(6):871-880. PubMed ID: 28932914
[TBL] [Abstract][Full Text] [Related]
14. Willingness to Pay for Health-Related Quality of Life Gains in Relation to Disease Severity and the Age of Patients.
Reckers-Droog V; van Exel J; Brouwer W
Value Health; 2021 Aug; 24(8):1182-1192. PubMed ID: 34372984
[TBL] [Abstract][Full Text] [Related]
15. The impact of the design of payment scales on the willingness to pay for health gains.
Soeteman L; van Exel J; Bobinac A
Eur J Health Econ; 2017 Jul; 18(6):743-760. PubMed ID: 27623946
[TBL] [Abstract][Full Text] [Related]
16. Sample restrictions and the elicitation of a constant willingness to pay per quality adjusted life year.
Nielsen JS; Gyrd-Hansen D; Kjaer T
Health Econ; 2021 May; 30(5):923-931. PubMed ID: 33569834
[TBL] [Abstract][Full Text] [Related]
17. Willingness to pay for QALY: perspectives and contexts in Japan.
Igarashi A; Goto R; Yoneyama-Hirozane M
J Med Econ; 2019 Oct; 22(10):1041-1046. PubMed ID: 31262236
[No Abstract] [Full Text] [Related]
18. GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation.
Bobinac A; van Exel NJ; Rutten FF; Brouwer WB
J Health Econ; 2012 Jan; 31(1):158-68. PubMed ID: 22018622
[TBL] [Abstract][Full Text] [Related]
19. Handling Protest Responses in Contingent Valuation Surveys.
Pennington M; Gomes M; Donaldson C
Med Decis Making; 2017 Aug; 37(6):623-634. PubMed ID: 28199176
[TBL] [Abstract][Full Text] [Related]
20. Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis.
Byrne MM; O'malley K; Suarez-Almazor ME
Med Decis Making; 2005; 25(6):655-66. PubMed ID: 16282216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
